NCT03713060

Brief Summary

Background Roux-en-Y gastric bypass (RYGB) is a well-established treatment of obesity, most often performed in women during their reproductive years. Adverse events related to RYGB include hypoglycemia. Though usually attenuated in pregnancy, the incretin response is reinforced in subjects with RYGB and the resulting changes in insulin and glucagon responses together with the resultant weight loss are possible underlying mechanisms for hypoglycemia. The majorities of women who have undergone RYGB conceive shortly after RYGB and have an increased risk for inappropriate gestational weight gain (GWG) and thereby fetal growth restriction. However, studies of hypoglycemia and GWG in pregnant women following RYGB are lacking. Objective In women with previous RYGB we aim to investigate a) glucose level and incretin response during a mixed meal test (MMT) in early and late pregnancy, b) trimester specific incidence of postprandial hypoglycemia and c) fetal growth. Methods 20 women with RYGB and 20 age-, BMI- and parity-matched controls will be studied with a) 2nd and 3rd trimester 4-hour liquid MMTs, b) 6-days Continuous Glucose Monitoring (CGM) once every trimester and post partum and c) maternal and fetal anthropometrics including antenatal ultrasound examinations and neonatal DXA-scans. The primary outcomes are nadir plasma glucose levels during the 4-hour liquid MMT, number of hypoglycemic episodes during CGM and birthweight standard deviation scores. Discussion A better understanding of maternal metabolism and fetal growth in women with RYGB will support risk stratification, patient information and management both before and during pregnancy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2019

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 15, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 19, 2018

Completed
6 months until next milestone

Study Start

First participant enrolled

April 17, 2019

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 11, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 11, 2022

Completed
Last Updated

July 18, 2022

Status Verified

July 1, 2022

Enrollment Period

3.2 years

First QC Date

October 15, 2018

Last Update Submit

July 15, 2022

Conditions

Keywords

PregnancyGastric bypassHypoglycemiaGestational weight gainFetal growth

Outcome Measures

Primary Outcomes (3)

  • Plasma glucose

    Nadir plasma glucose levels during a 4-hour liquid MMT

    Changes in plasma glucose during 4 hour test

  • Plasma glucose

    Number of hypoglycemic episodes during CGM

    Nuber of episodes during 14 days monitoring

  • Z-score

    Birthweight standard deviation score

    Measured immediately after birth

Study Arms (2)

Women with RYGB and fetus/ child

OTHER

20 pregnant women with previous gastric bypass surgery. During pregnancy the women will be tested with mixed meal test and continuous glucose monitoring for the diagnosis of hypoglycemia. Ultrasounds of fetal growth will be performed and after birth anthropometrics of the newborn will be meaured including a DXA-scan to estimate bodycomposition.

Diagnostic Test: Mixed meal test

Matched controls and fetus/ child

OTHER

20 pregnant women matched on age, prepregnancy-BMI and parity (n = 20). During pregnancy the women will be tested with mixed meal test and continuous glucose monitoring for the diagnosis of hypoglycemia. Ultrasounds of fetal growth will be performed and after birth anthropometrics of the newborn will be meaured including a DXA-scan to estimate bodycomposition.

Diagnostic Test: Mixed meal test

Interventions

Mixed meal testDIAGNOSTIC_TEST

All women will have mixed meal test, continous glucose monitoring and antenatal ultrasounds performed. The children born of these women will have DXA-scans performed after birth.

Also known as: Continous Glucose Monitoring, Antenatal ultrasounds, DXA-scan
Matched controls and fetus/ childWomen with RYGB and fetus/ child

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • GB group: pregnant women with RYGB (n = 20)
  • non-GB group: pregnant women matched on age, prepregnancy-BMI and parity (n = 20)
  • neonates: offspring of abovementioned women (n = 40)

You may not qualify if:

  • multiple pregnancy
  • age below 18 and above 45 years
  • ongoing smoking and substance abuse
  • severe psychiatric disorder
  • severe chronic disease
  • diabetes
  • women with pre-gestational diabetes (type1 or 2) prior to RYGB
  • women with Gestational Diabetes Mellitus (GDM) in a previous pregnancy will not be excluded

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Odense University Hospital

Odense, Fyn, 5000, Denmark

Location

Hospital of South West Jutland

Esbjerg, 6700, Denmark

Location

Related Publications (1)

  • Stentebjerg LL, Madsen LR, Stoving RK, Hartmann B, Holst JJ, Vinter C, Juhl CB, Hojlund K, Jensen DM. Altered postprandial glucose metabolism and enteropancreatic hormone responses during pregnancy following Roux-en-Y gastric bypass: a prospective cohort study. BMJ Open Diabetes Res Care. 2025 Mar 20;13(2):e004672. doi: 10.1136/bmjdrc-2024-004672.

MeSH Terms

Conditions

HypoglycemiaGestational Weight Gain

Interventions

Absorptiometry, Photon

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesWeight GainBody Weight ChangesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

RadiographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisDensitometryPhotometryChemistry Techniques, AnalyticalInvestigative Techniques

Study Officials

  • Louise L Stentebjerg, MD

    Clinical Institue, University of Southern Denmark

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investiagtor, MD, PhD-student

Study Record Dates

First Submitted

October 15, 2018

First Posted

October 19, 2018

Study Start

April 17, 2019

Primary Completion

July 11, 2022

Study Completion

July 11, 2022

Last Updated

July 18, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share

Locations